
CMX157 leverages our PIM (Phospholipid Intramembrane Microfluidization) Conjugate Technology with tenofovir, the molecule underlying… Read More

Chimerix is applying its powerful PIM (Phospholipid Intramembrane Microfluidization) Conjugate Technology to existing antiviral compounds with the goal… Read More